Latest Intelligence Brief Available Now
METIS
FEMTECH CONSULTANCY
Strategic Customer Success Intelligence for Women’s Health Technology Platforms
Metis helps women’s health technology platforms design AI-native engagement systems that sustain trust, participation, and long-term outcomes across hormone-driven health journeys.
You’ll be taken to a secure page to access the brief.
The Next Challenge for Women’s Health Technology
Women’s health platforms are transforming access to care across menstrual health, fertility, pregnancy, and menopause. Yet sustaining meaningful engagement across these health journeys remains one of the most significant challenges facing digital health innovators.
As artificial intelligence reshapes digital platforms, companies must rethink how engagement, retention, and outcomes are supported over time.
Metis helps organizations design the engagement architectures needed for this next phase of innovation.
Advisory for AI-Native Customer Success
Metis works with women’s health platforms to design engagement systems that support long-term participation and outcomes.
Core Advisory Areas:
Engagement Intelligence Architecture
Design predictive engagement systems that detect early signals of disengagement.
Lifecycle Engagement Strategy
Map engagement across hormone-driven health journeys from menstrual health to menopause.
Retention & Outcomes Measurement
Develop metrics that connect engagement, health outcomes, and revenue sustainability.
About
Carla Moss
Carla Moss is the Founder & Principal of Metis FemTech Consultancy and a seasoned customer success strategist, digital health advisor, and National Board-Certified Health and Wellness Coach.
Drawing on over fifteen years of experience in customer success management and digital health strategy, Carla works at the intersection of women's health innovation, behavioral engagement, and AI-native customer success systems.
Her work focuses on helping women's health platforms sustain meaningful engagement across hormone-driven health journeys.
Connect
For partnership inquiries or advisory conversations: